Coronavirus: BioNTech may become first foreign vaccine approved for use in mainland China

• The panel advising the country’s regulator gave the green light to the jab, which will be the first using cutting-edge mRNA technology on offer on the mainland
• China looks set to use the drug as a booster for those who have received two shots of home-made vaccines